DocGo (NASDAQ:DCGO – Get Free Report) had its price objective reduced by investment analysts at Needham & Company LLC from $7.00 to $4.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target suggests a potential upside of 29.45% from the company’s current price.
DocGo Trading Down 21.2 %
DCGO opened at $3.09 on Friday. The business’s 50 day moving average is $4.58 and its 200-day moving average is $4.02. The stock has a market cap of $315.34 million, a PE ratio of 11.04, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00. DocGo has a twelve month low of $2.75 and a twelve month high of $5.68.
Insider Buying and Selling
In related news, General Counsel Ely D. Tendler sold 23,088 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.70% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On DocGo
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
- Five stocks we like better than DocGo
- Conference Calls and Individual Investors
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How to start investing in penny stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What is MarketRank™? How to Use it
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.